avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Snai1
|
ENSMUSG00000042821.8 | Snai1 |
Zeb1
|
ENSMUSG00000024238.16 | Zeb1 |
Snai2
|
ENSMUSG00000022676.8 | Snai2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Snai1 | mm39_v1_chr2_+_167380112_167380130 | 0.37 | 2.7e-02 | Click! |
Snai2 | mm39_v1_chr16_+_14523696_14523722 | -0.37 | 2.7e-02 | Click! |
Zeb1 | mm39_v1_chr18_+_5593566_5593602 | -0.34 | 4.1e-02 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_-_137157824 | 17.03 |
ENSMUST00000102522.5
|
Cela3b
|
chymotrypsin-like elastase family, member 3B |
chr2_-_28453374 | 12.22 |
ENSMUST00000028161.6
|
Cel
|
carboxyl ester lipase |
chr6_-_41012435 | 7.00 |
ENSMUST00000031931.6
|
2210010C04Rik
|
RIKEN cDNA 2210010C04 gene |
chr8_-_106660470 | 6.64 |
ENSMUST00000034368.8
|
Ctrl
|
chymotrypsin-like |
chr13_-_63036096 | 5.84 |
ENSMUST00000092888.11
|
Fbp1
|
fructose bisphosphatase 1 |
chr9_+_46180362 | 5.72 |
ENSMUST00000214202.2
ENSMUST00000215458.2 ENSMUST00000215187.2 ENSMUST00000213878.2 ENSMUST00000034584.4 |
Apoa5
|
apolipoprotein A-V |
chr6_+_30639217 | 5.30 |
ENSMUST00000031806.10
|
Cpa1
|
carboxypeptidase A1, pancreatic |
chr4_-_137137088 | 5.26 |
ENSMUST00000024200.7
|
Cela3a
|
chymotrypsin-like elastase family, member 3A |
chr7_-_126651847 | 5.18 |
ENSMUST00000205424.2
|
Zg16
|
zymogen granule protein 16 |
chr8_-_112417633 | 5.08 |
ENSMUST00000034435.7
|
Ctrb1
|
chymotrypsinogen B1 |
chr3_-_20329823 | 4.95 |
ENSMUST00000011607.6
|
Cpb1
|
carboxypeptidase B1 (tissue) |
chr6_+_41435846 | 4.91 |
ENSMUST00000031910.8
|
Prss1
|
protease, serine 1 (trypsin 1) |
chr6_+_41331039 | 4.68 |
ENSMUST00000072103.7
|
Try10
|
trypsin 10 |
chr3_-_107129038 | 4.07 |
ENSMUST00000029504.9
|
Cym
|
chymosin |
chr6_+_41369290 | 4.06 |
ENSMUST00000049079.9
|
Gm5771
|
predicted gene 5771 |
chr7_-_142233270 | 3.94 |
ENSMUST00000162317.2
ENSMUST00000125933.2 ENSMUST00000105931.8 ENSMUST00000105930.8 ENSMUST00000105933.8 ENSMUST00000105932.2 ENSMUST00000000220.3 |
Ins2
|
insulin II |
chr1_-_134162231 | 3.81 |
ENSMUST00000169927.2
|
Adora1
|
adenosine A1 receptor |
chr17_+_23898223 | 3.72 |
ENSMUST00000024699.4
ENSMUST00000232719.2 |
Cldn6
|
claudin 6 |
chr14_-_31362835 | 3.66 |
ENSMUST00000167066.8
ENSMUST00000127204.9 |
Hacl1
|
2-hydroxyacyl-CoA lyase 1 |
chr19_+_52252735 | 3.63 |
ENSMUST00000039652.6
|
Ins1
|
insulin I |
chr4_+_133246274 | 3.63 |
ENSMUST00000149807.2
ENSMUST00000042919.16 ENSMUST00000153811.2 ENSMUST00000105901.2 ENSMUST00000121797.2 |
Kdf1
|
keratinocyte differentiation factor 1 |
chr14_-_31362909 | 3.53 |
ENSMUST00000022437.16
|
Hacl1
|
2-hydroxyacyl-CoA lyase 1 |
chr6_-_41291634 | 3.45 |
ENSMUST00000064324.12
|
Try5
|
trypsin 5 |
chr2_-_30364219 | 3.41 |
ENSMUST00000065134.4
|
Ier5l
|
immediate early response 5-like |
chr17_+_28988354 | 3.30 |
ENSMUST00000233109.2
ENSMUST00000004986.14 |
Mapk13
|
mitogen-activated protein kinase 13 |
chr19_-_3736549 | 3.24 |
ENSMUST00000025856.17
ENSMUST00000176867.2 |
Lrp5
|
low density lipoprotein receptor-related protein 5 |
chr7_+_140343652 | 3.21 |
ENSMUST00000026552.9
ENSMUST00000209253.2 ENSMUST00000210235.2 |
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1 |
chr11_+_69856222 | 3.21 |
ENSMUST00000018713.13
|
Cldn7
|
claudin 7 |
chr7_+_18618605 | 3.12 |
ENSMUST00000032573.8
|
Pglyrp1
|
peptidoglycan recognition protein 1 |
chr4_+_133280680 | 3.11 |
ENSMUST00000042706.3
|
Nr0b2
|
nuclear receptor subfamily 0, group B, member 2 |
chr6_+_78402956 | 3.09 |
ENSMUST00000079926.6
|
Reg1
|
regenerating islet-derived 1 |
chr5_-_134776101 | 3.03 |
ENSMUST00000015138.13
|
Eln
|
elastin |
chr3_-_108443769 | 2.98 |
ENSMUST00000048012.13
ENSMUST00000106625.10 |
Elapor1
|
endosome-lysosome associated apoptosis and autophagy regulator 1 |
chr12_-_113386312 | 2.95 |
ENSMUST00000177715.8
ENSMUST00000103426.3 |
Ighm
|
immunoglobulin heavy constant mu |
chr17_+_28988271 | 2.95 |
ENSMUST00000233984.2
ENSMUST00000233460.2 |
Mapk13
|
mitogen-activated protein kinase 13 |
chrX_+_100427331 | 2.93 |
ENSMUST00000119190.2
|
Gjb1
|
gap junction protein, beta 1 |
chr5_+_135717890 | 2.93 |
ENSMUST00000005651.13
ENSMUST00000122113.8 |
Por
|
P450 (cytochrome) oxidoreductase |
chr11_-_59927688 | 2.89 |
ENSMUST00000102692.10
|
Pemt
|
phosphatidylethanolamine N-methyltransferase |
chr10_-_127724557 | 2.88 |
ENSMUST00000047199.5
|
Rdh7
|
retinol dehydrogenase 7 |
chr6_-_41354538 | 2.83 |
ENSMUST00000096003.7
|
Prss3
|
protease, serine 3 |
chr7_-_30814652 | 2.73 |
ENSMUST00000168884.8
ENSMUST00000108102.9 |
Hpn
|
hepsin |
chr7_+_25872836 | 2.70 |
ENSMUST00000082214.5
|
Cyp2b9
|
cytochrome P450, family 2, subfamily b, polypeptide 9 |
chr5_+_135015046 | 2.69 |
ENSMUST00000094245.4
|
Cldn3
|
claudin 3 |
chr7_-_28981335 | 2.69 |
ENSMUST00000108236.5
ENSMUST00000098604.12 |
Spint2
|
serine protease inhibitor, Kunitz type 2 |
chr7_+_127400016 | 2.66 |
ENSMUST00000106271.2
ENSMUST00000138432.2 |
Hsd3b7
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
chr9_-_57590926 | 2.65 |
ENSMUST00000034860.5
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2 |
chr15_-_75881289 | 2.65 |
ENSMUST00000170153.2
|
Fam83h
|
family with sequence similarity 83, member H |
chr1_+_88139678 | 2.64 |
ENSMUST00000073049.7
|
Ugt1a1
|
UDP glucuronosyltransferase 1 family, polypeptide A1 |
chr17_+_29312737 | 2.62 |
ENSMUST00000023829.8
ENSMUST00000233296.2 |
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A (P21) |
chr14_+_40827317 | 2.61 |
ENSMUST00000047286.7
|
Mat1a
|
methionine adenosyltransferase I, alpha |
chr9_-_118986123 | 2.60 |
ENSMUST00000010795.5
|
Acaa1b
|
acetyl-Coenzyme A acyltransferase 1B |
chr7_-_142211203 | 2.53 |
ENSMUST00000097936.9
ENSMUST00000000033.12 |
Igf2
|
insulin-like growth factor 2 |
chr11_+_103061905 | 2.45 |
ENSMUST00000042286.12
ENSMUST00000218163.2 |
Fmnl1
|
formin-like 1 |
chr7_-_126303351 | 2.43 |
ENSMUST00000106364.8
|
Coro1a
|
coronin, actin binding protein 1A |
chr17_-_56424265 | 2.39 |
ENSMUST00000113072.3
|
Plin5
|
perilipin 5 |
chr17_+_57369231 | 2.39 |
ENSMUST00000097299.10
ENSMUST00000169543.8 ENSMUST00000163763.2 |
Crb3
|
crumbs family member 3 |
chr15_-_100583044 | 2.39 |
ENSMUST00000230312.2
|
Cela1
|
chymotrypsin-like elastase family, member 1 |
chr19_+_41970148 | 2.37 |
ENSMUST00000026170.3
|
Ubtd1
|
ubiquitin domain containing 1 |
chr3_+_89136353 | 2.34 |
ENSMUST00000041142.4
|
Muc1
|
mucin 1, transmembrane |
chr11_-_100288566 | 2.33 |
ENSMUST00000001592.15
ENSMUST00000107403.2 |
Jup
|
junction plakoglobin |
chr11_+_73090270 | 2.30 |
ENSMUST00000006105.7
|
Shpk
|
sedoheptulokinase |
chr4_-_41640321 | 2.30 |
ENSMUST00000127306.2
|
Enho
|
energy homeostasis associated |
chr15_-_78687216 | 2.28 |
ENSMUST00000164826.8
|
Card10
|
caspase recruitment domain family, member 10 |
chr1_+_171041539 | 2.28 |
ENSMUST00000005820.11
ENSMUST00000075469.12 ENSMUST00000155126.8 |
Nr1i3
|
nuclear receptor subfamily 1, group I, member 3 |
chr5_-_145946408 | 2.26 |
ENSMUST00000138870.2
ENSMUST00000068317.13 |
Cyp3a25
|
cytochrome P450, family 3, subfamily a, polypeptide 25 |
chr10_-_128237087 | 2.25 |
ENSMUST00000042666.13
|
Slc39a5
|
solute carrier family 39 (metal ion transporter), member 5 |
chr7_+_125871761 | 2.25 |
ENSMUST00000056028.11
|
Sbk1
|
SH3-binding kinase 1 |
chr16_-_23709564 | 2.22 |
ENSMUST00000004480.5
|
Sst
|
somatostatin |
chr17_+_23898633 | 2.21 |
ENSMUST00000233364.2
|
Cldn6
|
claudin 6 |
chr6_+_41279199 | 2.20 |
ENSMUST00000031913.5
|
Try4
|
trypsin 4 |
chrX_+_100420873 | 2.11 |
ENSMUST00000052130.14
|
Gjb1
|
gap junction protein, beta 1 |
chr2_+_25293056 | 2.11 |
ENSMUST00000071442.12
|
Npdc1
|
neural proliferation, differentiation and control 1 |
chr15_-_74635423 | 2.11 |
ENSMUST00000040404.8
|
Ly6d
|
lymphocyte antigen 6 complex, locus D |
chr2_+_25293140 | 2.09 |
ENSMUST00000154809.8
ENSMUST00000055921.14 ENSMUST00000141567.8 |
Npdc1
|
neural proliferation, differentiation and control 1 |
chr9_-_21223551 | 2.07 |
ENSMUST00000003397.9
ENSMUST00000213250.2 |
Ap1m2
|
adaptor protein complex AP-1, mu 2 subunit |
chr1_+_133291302 | 2.06 |
ENSMUST00000135222.9
|
Etnk2
|
ethanolamine kinase 2 |
chr10_+_75771407 | 2.05 |
ENSMUST00000058906.7
|
Chchd10
|
coiled-coil-helix-coiled-coil-helix domain containing 10 |
chr14_+_40827108 | 2.05 |
ENSMUST00000224514.2
|
Mat1a
|
methionine adenosyltransferase I, alpha |
chr16_-_18880821 | 2.05 |
ENSMUST00000200568.2
|
Iglc1
|
immunoglobulin lambda constant 1 |
chr17_-_45997132 | 2.04 |
ENSMUST00000113523.9
|
Tmem63b
|
transmembrane protein 63b |
chr3_-_113166153 | 2.04 |
ENSMUST00000098673.5
|
Amy2a5
|
amylase 2a5 |
chr1_+_93062962 | 2.03 |
ENSMUST00000027491.7
|
Agxt
|
alanine-glyoxylate aminotransferase |
chr14_+_31363004 | 2.03 |
ENSMUST00000090147.7
|
Btd
|
biotinidase |
chr9_-_46146558 | 2.01 |
ENSMUST00000121916.8
ENSMUST00000034586.9 |
Apoc3
|
apolipoprotein C-III |
chr4_-_141553306 | 2.00 |
ENSMUST00000102481.4
|
Cela2a
|
chymotrypsin-like elastase family, member 2A |
chr15_-_100579450 | 2.00 |
ENSMUST00000230740.2
|
Cela1
|
chymotrypsin-like elastase family, member 1 |
chr5_+_135698881 | 1.99 |
ENSMUST00000153500.8
|
Por
|
P450 (cytochrome) oxidoreductase |
chr11_-_5102218 | 1.98 |
ENSMUST00000163299.8
ENSMUST00000062821.13 |
Emid1
|
EMI domain containing 1 |
chr17_-_47040083 | 1.98 |
ENSMUST00000002846.9
|
Gnmt
|
glycine N-methyltransferase |
chr15_-_76543889 | 1.97 |
ENSMUST00000231152.2
|
Cyhr1
|
cysteine and histidine rich 1 |
chr7_+_13467422 | 1.97 |
ENSMUST00000086148.8
|
Sult2a2
|
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 2 |
chr14_+_40826970 | 1.96 |
ENSMUST00000225720.2
|
Mat1a
|
methionine adenosyltransferase I, alpha |
chr6_-_88851579 | 1.95 |
ENSMUST00000061262.11
ENSMUST00000140455.8 ENSMUST00000145780.2 |
Podxl2
|
podocalyxin-like 2 |
chr11_+_115714853 | 1.94 |
ENSMUST00000103032.11
ENSMUST00000133250.8 ENSMUST00000177736.8 |
Llgl2
|
LLGL2 scribble cell polarity complex component |
chr14_-_47426863 | 1.93 |
ENSMUST00000089959.7
|
Gch1
|
GTP cyclohydrolase 1 |
chr1_+_171041583 | 1.92 |
ENSMUST00000111328.8
|
Nr1i3
|
nuclear receptor subfamily 1, group I, member 3 |
chr14_-_70588803 | 1.92 |
ENSMUST00000143153.2
ENSMUST00000127000.2 ENSMUST00000068044.14 ENSMUST00000022688.10 |
Slc39a14
|
solute carrier family 39 (zinc transporter), member 14 |
chrX_-_161747552 | 1.90 |
ENSMUST00000038769.3
|
S100g
|
S100 calcium binding protein G |
chr3_-_113325938 | 1.90 |
ENSMUST00000132353.2
|
Amy2a1
|
amylase 2a1 |
chr1_-_134163102 | 1.90 |
ENSMUST00000187631.2
ENSMUST00000038191.8 ENSMUST00000086465.6 |
Adora1
|
adenosine A1 receptor |
chr6_-_70051586 | 1.89 |
ENSMUST00000103377.3
|
Igkv6-32
|
immunoglobulin kappa variable 6-32 |
chr1_+_92934050 | 1.89 |
ENSMUST00000059676.5
|
Aqp12
|
aquaporin 12 |
chr5_+_146016064 | 1.89 |
ENSMUST00000035571.10
|
Cyp3a59
|
cytochrome P450, family 3, subfamily a, polypeptide 59 |
chr8_-_70892204 | 1.86 |
ENSMUST00000076615.6
|
Crtc1
|
CREB regulated transcription coactivator 1 |
chr1_+_153616090 | 1.86 |
ENSMUST00000027748.8
|
Rgs16
|
regulator of G-protein signaling 16 |
chr4_-_154384305 | 1.85 |
ENSMUST00000154895.2
|
Arhgef16
|
Rho guanine nucleotide exchange factor (GEF) 16 |
chr4_-_130169335 | 1.84 |
ENSMUST00000154846.2
ENSMUST00000105996.8 |
Serinc2
|
serine incorporator 2 |
chr3_-_113263974 | 1.84 |
ENSMUST00000098667.5
|
Amy2a2
|
amylase 2a2 |
chr6_-_41423004 | 1.83 |
ENSMUST00000095999.7
|
Gm10334
|
predicted gene 10334 |
chr1_+_72863641 | 1.82 |
ENSMUST00000047328.11
|
Igfbp2
|
insulin-like growth factor binding protein 2 |
chr7_+_44866635 | 1.82 |
ENSMUST00000097216.5
ENSMUST00000209343.2 ENSMUST00000209678.2 |
Tead2
|
TEA domain family member 2 |
chr10_-_78188153 | 1.81 |
ENSMUST00000001240.12
|
Agpat3
|
1-acylglycerol-3-phosphate O-acyltransferase 3 |
chr3_-_89300599 | 1.81 |
ENSMUST00000142119.2
ENSMUST00000029677.9 ENSMUST00000148361.8 |
Zbtb7b
|
zinc finger and BTB domain containing 7B |
chr10_-_128236317 | 1.81 |
ENSMUST00000167859.2
ENSMUST00000218858.2 |
Slc39a5
|
solute carrier family 39 (metal ion transporter), member 5 |
chr4_-_154384464 | 1.81 |
ENSMUST00000030898.12
|
Arhgef16
|
Rho guanine nucleotide exchange factor (GEF) 16 |
chr4_+_137434767 | 1.81 |
ENSMUST00000097837.11
|
Rap1gap
|
Rap1 GTPase-activating protein |
chr17_+_14499793 | 1.80 |
ENSMUST00000233344.2
ENSMUST00000232923.2 |
Smoc2
|
SPARC related modular calcium binding 2 |
chr4_+_118217179 | 1.80 |
ENSMUST00000006562.6
|
Hyi
|
hydroxypyruvate isomerase (putative) |
chr4_+_118384426 | 1.79 |
ENSMUST00000030261.6
|
2610528J11Rik
|
RIKEN cDNA 2610528J11 gene |
chr3_-_113198765 | 1.79 |
ENSMUST00000179568.3
|
Amy2a4
|
amylase 2a4 |
chr11_-_115258508 | 1.77 |
ENSMUST00000044152.13
ENSMUST00000106542.9 |
Hid1
|
HID1 domain containing |
chr13_-_55574596 | 1.76 |
ENSMUST00000021948.15
|
F12
|
coagulation factor XII (Hageman factor) |
chr3_+_94280101 | 1.76 |
ENSMUST00000029795.10
|
Rorc
|
RAR-related orphan receptor gamma |
chr19_+_3758285 | 1.75 |
ENSMUST00000237320.2
ENSMUST00000039048.2 ENSMUST00000235295.2 ENSMUST00000237955.2 ENSMUST00000235837.2 |
1810055G02Rik
|
RIKEN cDNA 1810055G02 gene |
chr12_+_81073573 | 1.73 |
ENSMUST00000110347.9
ENSMUST00000021564.11 ENSMUST00000129362.2 |
Smoc1
|
SPARC related modular calcium binding 1 |
chr10_-_116786271 | 1.72 |
ENSMUST00000020375.7
ENSMUST00000219109.2 |
Rab3ip
|
RAB3A interacting protein |
chr10_-_78187887 | 1.72 |
ENSMUST00000105388.8
|
Agpat3
|
1-acylglycerol-3-phosphate O-acyltransferase 3 |
chr9_-_57375269 | 1.72 |
ENSMUST00000215059.2
ENSMUST00000046587.8 ENSMUST00000214256.2 |
Scamp5
|
secretory carrier membrane protein 5 |
chr5_-_122187884 | 1.72 |
ENSMUST00000111752.10
|
Cux2
|
cut-like homeobox 2 |
chr17_-_56428968 | 1.71 |
ENSMUST00000041357.9
|
Lrg1
|
leucine-rich alpha-2-glycoprotein 1 |
chr17_-_56424577 | 1.70 |
ENSMUST00000019808.12
|
Plin5
|
perilipin 5 |
chr7_-_4792530 | 1.69 |
ENSMUST00000168578.3
|
Tmem238
|
transmembrane protein 238 |
chrX_-_51702790 | 1.68 |
ENSMUST00000069360.14
|
Gpc3
|
glypican 3 |
chr17_+_14499768 | 1.68 |
ENSMUST00000024660.9
|
Smoc2
|
SPARC related modular calcium binding 2 |
chr4_-_130169006 | 1.67 |
ENSMUST00000122374.8
|
Serinc2
|
serine incorporator 2 |
chr7_-_140680437 | 1.67 |
ENSMUST00000210167.2
ENSMUST00000209294.2 ENSMUST00000097958.3 |
Sigirr
|
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
chr8_-_110688716 | 1.66 |
ENSMUST00000001722.14
ENSMUST00000051430.7 |
Marveld3
|
MARVEL (membrane-associating) domain containing 3 |
chr17_-_31363245 | 1.65 |
ENSMUST00000024826.8
|
Tff2
|
trefoil factor 2 (spasmolytic protein 1) |
chr8_-_123187406 | 1.65 |
ENSMUST00000006762.7
|
Snai3
|
snail family zinc finger 3 |
chr7_-_30776081 | 1.65 |
ENSMUST00000072331.13
ENSMUST00000167369.8 |
Fxyd3
|
FXYD domain-containing ion transport regulator 3 |
chr13_-_55574582 | 1.64 |
ENSMUST00000170921.2
|
F12
|
coagulation factor XII (Hageman factor) |
chr11_-_75313350 | 1.64 |
ENSMUST00000125982.2
ENSMUST00000137103.8 |
Serpinf1
|
serine (or cysteine) peptidase inhibitor, clade F, member 1 |
chr8_+_72050292 | 1.63 |
ENSMUST00000143662.8
|
Niban3
|
niban apoptosis regulator 3 |
chr10_-_24803336 | 1.62 |
ENSMUST00000020161.10
|
Arg1
|
arginase, liver |
chr8_-_4309257 | 1.61 |
ENSMUST00000053252.9
|
Ctxn1
|
cortexin 1 |
chr10_+_75399920 | 1.60 |
ENSMUST00000141062.8
ENSMUST00000152657.8 |
Ggt1
|
gamma-glutamyltransferase 1 |
chr11_+_120421496 | 1.60 |
ENSMUST00000026119.8
|
Gcgr
|
glucagon receptor |
chr7_-_30643444 | 1.59 |
ENSMUST00000062620.9
|
Hamp
|
hepcidin antimicrobial peptide |
chr18_-_35782412 | 1.57 |
ENSMUST00000025211.6
|
Mzb1
|
marginal zone B and B1 cell-specific protein 1 |
chr8_-_84874468 | 1.56 |
ENSMUST00000117424.9
ENSMUST00000040383.9 |
Cc2d1a
|
coiled-coil and C2 domain containing 1A |
chr7_+_140795765 | 1.55 |
ENSMUST00000046890.12
ENSMUST00000209500.2 |
Rassf7
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7 |
chr13_-_42001075 | 1.55 |
ENSMUST00000179758.8
|
Adtrp
|
androgen dependent TFPI regulating protein |
chr8_+_85717210 | 1.55 |
ENSMUST00000209764.2
ENSMUST00000064495.8 ENSMUST00000210326.2 |
Hook2
|
hook microtubule tethering protein 2 |
chr17_-_45997046 | 1.55 |
ENSMUST00000143907.3
ENSMUST00000127065.8 |
Tmem63b
|
transmembrane protein 63b |
chr10_-_116786350 | 1.54 |
ENSMUST00000218391.2
|
Rab3ip
|
RAB3A interacting protein |
chr4_+_49059255 | 1.54 |
ENSMUST00000076670.3
|
Plppr1
|
phospholipid phosphatase related 1 |
chr14_-_30645503 | 1.53 |
ENSMUST00000227995.2
|
Itih3
|
inter-alpha trypsin inhibitor, heavy chain 3 |
chr10_+_75784126 | 1.52 |
ENSMUST00000000926.3
|
Vpreb3
|
pre-B lymphocyte gene 3 |
chr7_+_127399776 | 1.52 |
ENSMUST00000046863.12
ENSMUST00000206674.2 ENSMUST00000106272.8 |
Hsd3b7
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
chr15_-_103446354 | 1.51 |
ENSMUST00000023133.8
|
Ppp1r1a
|
protein phosphatase 1, regulatory inhibitor subunit 1A |
chr7_-_126303689 | 1.50 |
ENSMUST00000135087.8
|
Coro1a
|
coronin, actin binding protein 1A |
chr10_-_128236366 | 1.50 |
ENSMUST00000219131.2
|
Slc39a5
|
solute carrier family 39 (metal ion transporter), member 5 |
chr3_-_89300936 | 1.49 |
ENSMUST00000124783.8
ENSMUST00000126027.8 |
Zbtb7b
|
zinc finger and BTB domain containing 7B |
chr1_+_92862432 | 1.49 |
ENSMUST00000117814.8
|
Capn10
|
calpain 10 |
chr5_-_145406533 | 1.48 |
ENSMUST00000031633.5
|
Cyp3a16
|
cytochrome P450, family 3, subfamily a, polypeptide 16 |
chr16_-_17394495 | 1.48 |
ENSMUST00000231645.2
ENSMUST00000232226.2 ENSMUST00000232336.2 ENSMUST00000232385.2 ENSMUST00000231615.2 ENSMUST00000231283.2 ENSMUST00000172164.10 |
Slc7a4
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 4 |
chr7_+_30673212 | 1.47 |
ENSMUST00000129773.2
|
Fam187b
|
family with sequence similarity 187, member B |
chr16_-_18884431 | 1.47 |
ENSMUST00000200235.2
|
Iglc3
|
immunoglobulin lambda constant 3 |
chr1_-_171023798 | 1.46 |
ENSMUST00000111332.2
|
Pcp4l1
|
Purkinje cell protein 4-like 1 |
chr2_-_155571279 | 1.46 |
ENSMUST00000040833.5
|
Edem2
|
ER degradation enhancer, mannosidase alpha-like 2 |
chr11_-_62539284 | 1.46 |
ENSMUST00000057194.9
|
Lrrc75a
|
leucine rich repeat containing 75A |
chr3_-_92393193 | 1.46 |
ENSMUST00000054599.8
|
Sprr1a
|
small proline-rich protein 1A |
chr5_+_31409021 | 1.46 |
ENSMUST00000054829.13
ENSMUST00000201625.4 ENSMUST00000201937.4 |
Krtcap3
|
keratinocyte associated protein 3 |
chr5_-_108823435 | 1.45 |
ENSMUST00000051757.14
|
Slc26a1
|
solute carrier family 26 (sulfate transporter), member 1 |
chr1_-_153061758 | 1.44 |
ENSMUST00000185356.7
|
Lamc2
|
laminin, gamma 2 |
chr8_+_3637785 | 1.44 |
ENSMUST00000171962.3
ENSMUST00000207712.2 ENSMUST00000207970.2 ENSMUST00000207533.2 ENSMUST00000208240.2 ENSMUST00000207432.2 ENSMUST00000207077.2 |
Camsap3
|
calmodulin regulated spectrin-associated protein family, member 3 |
chr10_-_78187545 | 1.43 |
ENSMUST00000105390.8
|
Agpat3
|
1-acylglycerol-3-phosphate O-acyltransferase 3 |
chr2_+_32766126 | 1.42 |
ENSMUST00000028135.15
|
Niban2
|
niban apoptosis regulator 2 |
chr2_+_25285878 | 1.42 |
ENSMUST00000028328.3
|
Entpd2
|
ectonucleoside triphosphate diphosphohydrolase 2 |
chr7_-_19530714 | 1.41 |
ENSMUST00000108449.9
ENSMUST00000043822.8 |
Cblc
|
Casitas B-lineage lymphoma c |
chr15_+_102052797 | 1.41 |
ENSMUST00000023807.7
|
Igfbp6
|
insulin-like growth factor binding protein 6 |
chr12_-_73593157 | 1.40 |
ENSMUST00000042975.7
|
Tmem30b
|
transmembrane protein 30B |
chr9_-_46146928 | 1.40 |
ENSMUST00000118649.8
|
Apoc3
|
apolipoprotein C-III |
chr11_-_120930193 | 1.39 |
ENSMUST00000026159.6
|
Cd7
|
CD7 antigen |
chr10_-_78188046 | 1.38 |
ENSMUST00000146899.2
|
Agpat3
|
1-acylglycerol-3-phosphate O-acyltransferase 3 |
chr2_+_164404499 | 1.38 |
ENSMUST00000017867.10
ENSMUST00000109344.9 ENSMUST00000109345.9 |
Wfdc2
|
WAP four-disulfide core domain 2 |
chr19_+_46587523 | 1.38 |
ENSMUST00000138302.9
ENSMUST00000099376.11 |
Wbp1l
|
WW domain binding protein 1 like |
chr2_-_64853083 | 1.38 |
ENSMUST00000028252.14
|
Grb14
|
growth factor receptor bound protein 14 |
chr13_-_42000958 | 1.37 |
ENSMUST00000072012.10
|
Adtrp
|
androgen dependent TFPI regulating protein |
chr4_+_122889828 | 1.37 |
ENSMUST00000030407.8
|
Mycl
|
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived |
chr14_+_70815250 | 1.36 |
ENSMUST00000228554.2
|
Nudt18
|
nudix (nucleoside diphosphate linked moiety X)-type motif 18 |
chr11_+_3933699 | 1.36 |
ENSMUST00000063004.14
|
Gal3st1
|
galactose-3-O-sulfotransferase 1 |
chr9_+_110248815 | 1.36 |
ENSMUST00000035061.9
|
Ngp
|
neutrophilic granule protein |
chr14_-_123150497 | 1.36 |
ENSMUST00000162164.2
ENSMUST00000110679.9 ENSMUST00000161322.3 ENSMUST00000038075.12 |
Ggact
|
gamma-glutamylamine cyclotransferase |
chr2_+_119067832 | 1.36 |
ENSMUST00000028783.14
|
Spint1
|
serine protease inhibitor, Kunitz type 1 |
chr19_-_39875192 | 1.35 |
ENSMUST00000168838.3
|
Cyp2c69
|
cytochrome P450, family 2, subfamily c, polypeptide 69 |
chr2_+_167380112 | 1.35 |
ENSMUST00000052631.8
|
Snai1
|
snail family zinc finger 1 |
chr7_-_126817639 | 1.35 |
ENSMUST00000152267.8
ENSMUST00000106314.8 |
Septin1
|
septin 1 |
chr11_+_96920956 | 1.35 |
ENSMUST00000153482.2
|
Scrn2
|
secernin 2 |
chr8_+_120121612 | 1.35 |
ENSMUST00000098367.5
|
Mlycd
|
malonyl-CoA decarboxylase |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 6.6 | GO:0009087 | methionine catabolic process(GO:0009087) |
1.9 | 5.7 | GO:0032242 | positive regulation of nucleobase-containing compound transport(GO:0032241) regulation of nucleoside transport(GO:0032242) |
1.8 | 7.1 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
1.5 | 5.9 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
1.3 | 4.0 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
1.3 | 4.0 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.3 | 21.2 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
1.3 | 3.8 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
1.2 | 4.9 | GO:0090346 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
1.1 | 5.7 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
1.1 | 7.9 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
1.1 | 3.4 | GO:0002343 | peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
1.1 | 4.4 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
1.0 | 3.1 | GO:0034769 | basement membrane disassembly(GO:0034769) |
1.0 | 3.1 | GO:0051714 | regulation of cytolysis in other organism(GO:0051710) positive regulation of cytolysis in other organism(GO:0051714) |
1.0 | 3.9 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.9 | 2.7 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.9 | 2.6 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.9 | 4.4 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.8 | 2.5 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.8 | 3.2 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.8 | 5.7 | GO:0060309 | elastin catabolic process(GO:0060309) |
0.8 | 6.5 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.8 | 3.9 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
0.7 | 2.2 | GO:0006507 | GPI anchor release(GO:0006507) protein depalmitoleylation(GO:1990697) |
0.7 | 5.1 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.7 | 2.8 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
0.7 | 2.8 | GO:2000984 | regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
0.7 | 2.7 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.7 | 2.0 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
0.6 | 0.6 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.6 | 5.1 | GO:0031179 | peptide modification(GO:0031179) |
0.6 | 6.8 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.6 | 1.9 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.6 | 1.8 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
0.6 | 1.8 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
0.6 | 3.5 | GO:0002159 | desmosome assembly(GO:0002159) |
0.6 | 2.2 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
0.6 | 0.6 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.5 | 1.6 | GO:0021682 | nerve maturation(GO:0021682) |
0.5 | 3.7 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.5 | 1.5 | GO:1903538 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
0.5 | 3.6 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.5 | 1.5 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.5 | 2.0 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.5 | 0.5 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.5 | 1.5 | GO:0046710 | GDP metabolic process(GO:0046710) |
0.5 | 1.5 | GO:1904154 | trimming of terminal mannose on B branch(GO:0036509) positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.5 | 5.3 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.5 | 2.4 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) |
0.5 | 0.9 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.5 | 1.9 | GO:0015755 | fructose transport(GO:0015755) |
0.5 | 1.8 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.4 | 1.3 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
0.4 | 1.3 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.4 | 1.3 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
0.4 | 4.4 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.4 | 1.3 | GO:0030070 | insulin processing(GO:0030070) |
0.4 | 2.2 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.4 | 1.3 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.4 | 0.8 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
0.4 | 2.1 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.4 | 1.6 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
0.4 | 2.0 | GO:0070384 | Harderian gland development(GO:0070384) |
0.4 | 0.8 | GO:2001188 | negative regulation of immunological synapse formation(GO:2000521) regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001188) negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001189) |
0.4 | 1.2 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.4 | 1.2 | GO:0048627 | myoblast development(GO:0048627) |
0.4 | 1.2 | GO:0032827 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.4 | 1.9 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.4 | 0.4 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.4 | 1.1 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
0.4 | 1.1 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.4 | 1.1 | GO:1904092 | regulation of autophagic cell death(GO:1904092) negative regulation of autophagic cell death(GO:1904093) |
0.4 | 0.7 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.3 | 10.8 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.3 | 1.0 | GO:0072363 | regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072363) |
0.3 | 1.4 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.3 | 2.0 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.3 | 1.0 | GO:0008204 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
0.3 | 1.7 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
0.3 | 4.6 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.3 | 2.0 | GO:0032439 | endosome localization(GO:0032439) |
0.3 | 1.6 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.3 | 2.9 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.3 | 1.0 | GO:0071846 | actin filament debranching(GO:0071846) |
0.3 | 1.0 | GO:0015881 | creatine transport(GO:0015881) |
0.3 | 0.3 | GO:0034226 | lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
0.3 | 0.6 | GO:0002215 | defense response to nematode(GO:0002215) |
0.3 | 2.8 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.3 | 1.3 | GO:0015855 | nucleobase transport(GO:0015851) pyrimidine nucleobase transport(GO:0015855) |
0.3 | 0.6 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.3 | 0.9 | GO:1902222 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.3 | 1.2 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.3 | 0.6 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.3 | 1.5 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.3 | 0.9 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
0.3 | 0.9 | GO:0043181 | vacuolar sequestering(GO:0043181) |
0.3 | 1.5 | GO:0072181 | mesonephric duct formation(GO:0072181) |
0.3 | 2.4 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.3 | 0.9 | GO:0019860 | uracil catabolic process(GO:0006212) uracil metabolic process(GO:0019860) |
0.3 | 0.9 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.3 | 1.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.3 | 2.6 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.3 | 4.3 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.3 | 2.9 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.3 | 2.0 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.3 | 2.6 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.3 | 0.3 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.3 | 1.4 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.3 | 0.8 | GO:2000485 | asparagine transport(GO:0006867) regulation of glutamine transport(GO:2000485) positive regulation of glutamine transport(GO:2000487) |
0.3 | 0.8 | GO:0061623 | glycolytic process from galactose(GO:0061623) |
0.3 | 2.0 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.3 | 3.1 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.3 | 1.1 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.3 | 1.7 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.3 | 1.7 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.3 | 2.5 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.3 | 2.2 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.3 | 0.8 | GO:1902361 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
0.3 | 0.8 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
0.3 | 1.1 | GO:1901003 | negative regulation of fermentation(GO:1901003) |
0.3 | 2.4 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.3 | 0.8 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.3 | 2.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.3 | 0.8 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
0.3 | 0.8 | GO:0060157 | urinary bladder development(GO:0060157) |
0.3 | 0.5 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.3 | 1.3 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.3 | 1.1 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.3 | 0.5 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.3 | 1.1 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.3 | 2.4 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.3 | 1.3 | GO:0035989 | tendon development(GO:0035989) |
0.3 | 1.8 | GO:0033762 | response to glucagon(GO:0033762) |
0.3 | 2.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.3 | 0.8 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.3 | 0.5 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) |
0.3 | 2.8 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.3 | 1.5 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.3 | 0.3 | GO:1903181 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
0.3 | 3.5 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.2 | 1.2 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.2 | 1.0 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
0.2 | 0.5 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.2 | 1.0 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.2 | 1.0 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.2 | 1.9 | GO:0019532 | oxalate transport(GO:0019532) |
0.2 | 1.0 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.2 | 1.2 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.2 | 0.5 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.2 | 1.9 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.2 | 0.5 | GO:2000412 | positive regulation of thymocyte migration(GO:2000412) |
0.2 | 2.1 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.2 | 0.9 | GO:0072014 | proximal tubule development(GO:0072014) |
0.2 | 0.9 | GO:0015744 | succinate transport(GO:0015744) |
0.2 | 0.5 | GO:0030421 | defecation(GO:0030421) |
0.2 | 1.4 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 0.5 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.2 | 1.6 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.2 | 2.3 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.2 | 0.9 | GO:0046084 | adenine salvage(GO:0006168) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.2 | 1.4 | GO:0032902 | nerve growth factor production(GO:0032902) |
0.2 | 0.5 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 1.4 | GO:1903384 | neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) |
0.2 | 0.5 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.2 | 0.2 | GO:0018931 | naphthalene metabolic process(GO:0018931) naphthalene-containing compound metabolic process(GO:0090420) |
0.2 | 1.8 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.2 | 0.4 | GO:0061017 | hepatoblast differentiation(GO:0061017) |
0.2 | 0.7 | GO:1902220 | positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902220) |
0.2 | 0.2 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.2 | 1.8 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.2 | 0.4 | GO:0042670 | retinal cone cell differentiation(GO:0042670) |
0.2 | 0.7 | GO:0042488 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) |
0.2 | 1.7 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.2 | 3.1 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.2 | 1.3 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.2 | 1.1 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.2 | 1.1 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.2 | 1.9 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.2 | 1.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.2 | 0.6 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.2 | 3.6 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.2 | 0.2 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.2 | 1.1 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.2 | 0.2 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.2 | 30.7 | GO:0007586 | digestion(GO:0007586) |
0.2 | 2.3 | GO:0072615 | interleukin-17 secretion(GO:0072615) |
0.2 | 0.6 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.2 | 0.2 | GO:0002885 | positive regulation of hypersensitivity(GO:0002885) |
0.2 | 1.2 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.2 | 0.4 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.2 | 1.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 0.4 | GO:0072144 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.2 | 0.6 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
0.2 | 0.2 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.2 | 0.6 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
0.2 | 0.8 | GO:2000657 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
0.2 | 0.4 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
0.2 | 0.6 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
0.2 | 1.0 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.2 | 0.8 | GO:1902164 | positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.2 | 0.8 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.2 | 0.2 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.2 | 3.9 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.2 | 1.4 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.2 | 1.4 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.2 | 0.6 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.2 | 2.5 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.2 | 0.4 | GO:0097017 | renal protein absorption(GO:0097017) |
0.2 | 1.7 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 0.6 | GO:2000813 | negative regulation of barbed-end actin filament capping(GO:2000813) |
0.2 | 1.3 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.2 | 3.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.2 | 0.6 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.2 | 0.7 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.2 | 0.7 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.2 | 0.6 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.2 | 0.4 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.2 | 0.2 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
0.2 | 0.9 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.2 | 0.5 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
0.2 | 0.2 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.2 | 0.5 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.2 | 0.7 | GO:0035502 | metanephric part of ureteric bud development(GO:0035502) |
0.2 | 2.5 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.2 | 0.4 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.2 | 1.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 0.2 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.2 | 0.4 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.2 | 0.7 | GO:0006710 | androgen catabolic process(GO:0006710) |
0.2 | 0.9 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.2 | 0.7 | GO:0009814 | defense response, incompatible interaction(GO:0009814) defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
0.2 | 0.5 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
0.2 | 0.5 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.2 | 0.2 | GO:1900150 | regulation of defense response to fungus(GO:1900150) |
0.2 | 0.7 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.2 | 1.9 | GO:1901250 | regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
0.2 | 0.5 | GO:0097494 | regulation of vesicle size(GO:0097494) |
0.2 | 0.5 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.2 | 0.5 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.2 | 1.0 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.2 | 1.5 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.2 | 0.8 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.2 | 0.5 | GO:0002149 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
0.2 | 1.0 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) |
0.2 | 1.5 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.2 | 0.5 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
0.2 | 1.2 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.2 | 0.7 | GO:0034760 | negative regulation of iron ion transport(GO:0034757) negative regulation of iron ion transmembrane transport(GO:0034760) |
0.2 | 1.0 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 0.3 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 | 1.8 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 2.7 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.2 | 0.3 | GO:0042977 | regulation of activation of JAK2 kinase activity(GO:0010534) activation of JAK2 kinase activity(GO:0042977) negative regulation of activation of JAK2 kinase activity(GO:1902569) |
0.2 | 0.3 | GO:1904582 | positive regulation of intracellular mRNA localization(GO:1904582) |
0.2 | 0.2 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.2 | 0.2 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.2 | 0.3 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.2 | 0.8 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.2 | 0.8 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.2 | 1.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.2 | 0.2 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.2 | 1.3 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.2 | 1.6 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.2 | 1.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.2 | 0.6 | GO:0048880 | sensory system development(GO:0048880) |
0.2 | 0.3 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.2 | 0.2 | GO:0010226 | response to lithium ion(GO:0010226) cellular response to lithium ion(GO:0071285) |
0.2 | 1.8 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.2 | 1.2 | GO:1902564 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) negative regulation of neutrophil activation(GO:1902564) |
0.2 | 0.5 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
0.1 | 0.7 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.4 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 0.3 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.6 | GO:2000338 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.1 | 0.6 | GO:0071449 | response to lipid hydroperoxide(GO:0006982) cellular response to lipid hydroperoxide(GO:0071449) |
0.1 | 2.6 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.1 | 0.4 | GO:0032218 | riboflavin transport(GO:0032218) |
0.1 | 2.9 | GO:0001946 | lymphangiogenesis(GO:0001946) |
0.1 | 0.6 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.1 | 0.6 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.1 | 0.6 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.1 | 0.7 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
0.1 | 0.8 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.4 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.1 | 1.3 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.1 | GO:0036301 | macrophage colony-stimulating factor production(GO:0036301) granulocyte colony-stimulating factor production(GO:0071611) regulation of granulocyte colony-stimulating factor production(GO:0071655) regulation of macrophage colony-stimulating factor production(GO:1901256) |
0.1 | 0.6 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 1.4 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 0.8 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.9 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.9 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.3 | GO:0061218 | negative regulation of mesonephros development(GO:0061218) |
0.1 | 0.4 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.1 | 0.5 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.1 | 1.3 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 1.5 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 | 1.6 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.5 | GO:2000814 | positive regulation of barbed-end actin filament capping(GO:2000814) |
0.1 | 2.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.9 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.1 | 0.7 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.6 | GO:0072104 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.1 | 0.3 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
0.1 | 0.6 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.4 | GO:0015825 | L-serine transport(GO:0015825) |
0.1 | 0.5 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.1 | 2.4 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 1.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.1 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.1 | 0.8 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.1 | GO:0007037 | vacuolar phosphate transport(GO:0007037) positive regulation of parathyroid hormone secretion(GO:2000830) |
0.1 | 0.4 | GO:0044704 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) seminal vesicle development(GO:0061107) |
0.1 | 0.5 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.1 | 0.4 | GO:0046108 | uridine catabolic process(GO:0006218) uridine metabolic process(GO:0046108) |
0.1 | 0.4 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.1 | 1.7 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.6 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.1 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.1 | 0.5 | GO:0000239 | pachytene(GO:0000239) |
0.1 | 1.0 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.6 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.4 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 0.2 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.1 | 0.5 | GO:0046618 | drug export(GO:0046618) |
0.1 | 0.2 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.1 | 2.3 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 0.1 | GO:1904783 | positive regulation of NMDA glutamate receptor activity(GO:1904783) |
0.1 | 0.6 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
0.1 | 0.4 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.1 | 0.8 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.1 | 0.8 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 1.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 1.3 | GO:0046218 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.1 | 0.4 | GO:0060066 | oviduct development(GO:0060066) |
0.1 | 0.5 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.1 | 15.2 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.1 | 0.7 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.1 | 0.3 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.2 | GO:1903406 | regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) |
0.1 | 0.2 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.8 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.5 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.1 | 0.3 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.1 | 0.5 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 0.1 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.1 | 0.3 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.1 | 0.7 | GO:0097491 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.1 | 0.3 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
0.1 | 0.4 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.1 | 1.8 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 1.8 | GO:0042730 | fibrinolysis(GO:0042730) |
0.1 | 0.7 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.1 | 1.3 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.1 | 0.3 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.1 | 0.5 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.1 | 0.9 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.1 | 0.3 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 1.0 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
0.1 | 0.3 | GO:0051715 | cytolysis in other organism(GO:0051715) |
0.1 | 0.8 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.1 | 0.4 | GO:0060807 | cardiogenic plate morphogenesis(GO:0003142) stem cell fate specification(GO:0048866) regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification(GO:0060807) regulation of cardiac cell fate specification(GO:2000043) |
0.1 | 0.5 | GO:0032901 | positive regulation of neurotrophin production(GO:0032901) |
0.1 | 0.6 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.5 | GO:1990743 | protein sialylation(GO:1990743) |
0.1 | 0.9 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.1 | 1.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 14.2 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 0.4 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.1 | 0.2 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.1 | 0.5 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 0.1 | GO:0071726 | response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
0.1 | 0.7 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.1 | 1.5 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 0.4 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.1 | 0.6 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.1 | 0.2 | GO:0014064 | positive regulation of serotonin secretion(GO:0014064) |
0.1 | 0.5 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.1 | 0.1 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.1 | 0.1 | GO:2000410 | regulation of thymocyte migration(GO:2000410) |
0.1 | 0.4 | GO:2000303 | regulation of ceramide biosynthetic process(GO:2000303) |
0.1 | 0.2 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
0.1 | 0.1 | GO:1904393 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) |
0.1 | 0.5 | GO:0006548 | histidine metabolic process(GO:0006547) histidine catabolic process(GO:0006548) |
0.1 | 0.3 | GO:0071404 | cellular response to lipoprotein particle stimulus(GO:0071402) cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.1 | 0.3 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.3 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
0.1 | 0.3 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
0.1 | 1.3 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
0.1 | 0.3 | GO:0046135 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
0.1 | 0.5 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.1 | 0.4 | GO:0002266 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.1 | 0.4 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.1 | 0.5 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.1 | 0.2 | GO:0086047 | Purkinje myocyte action potential(GO:0086017) membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
0.1 | 0.4 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.1 | 0.3 | GO:0071939 | vitamin A transport(GO:0071938) vitamin A import(GO:0071939) |
0.1 | 2.5 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.1 | 0.3 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.1 | 1.5 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.1 | 0.4 | GO:0097048 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.1 | 1.0 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.1 | 2.2 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.1 | 0.2 | GO:0060983 | epicardium-derived cardiac vascular smooth muscle cell differentiation(GO:0060983) |
0.1 | 0.1 | GO:1901374 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.1 | 0.2 | GO:0035793 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.1 | 1.1 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.1 | 0.4 | GO:0061187 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.1 | 0.4 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.1 | 0.1 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.1 | 1.6 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 0.4 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.7 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.1 | 1.3 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.6 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.1 | 0.4 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) sodium-dependent self proteolysis(GO:1990091) |
0.1 | 0.3 | GO:0072720 | response to dithiothreitol(GO:0072720) |
0.1 | 0.6 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.1 | 1.0 | GO:0070471 | uterine smooth muscle contraction(GO:0070471) regulation of uterine smooth muscle contraction(GO:0070472) |
0.1 | 0.4 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 2.6 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 0.1 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.1 | 0.1 | GO:1904796 | regulation of core promoter binding(GO:1904796) positive regulation of core promoter binding(GO:1904798) |
0.1 | 0.4 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.1 | 0.3 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
0.1 | 0.2 | GO:0051933 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
0.1 | 0.1 | GO:0048846 | axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
0.1 | 0.5 | GO:0035089 | establishment of apical/basal cell polarity(GO:0035089) |
0.1 | 1.3 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.5 | GO:0099551 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
0.1 | 2.1 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.1 | 0.4 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.1 | 0.1 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.1 | 0.1 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.1 | 1.5 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.4 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.9 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.1 | 0.3 | GO:0042262 | DNA protection(GO:0042262) |
0.1 | 1.0 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.1 | 0.3 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.1 | 0.4 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 0.5 | GO:0071484 | cellular response to light intensity(GO:0071484) cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
0.1 | 0.8 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 1.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.3 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.1 | 0.4 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.1 | 0.3 | GO:0097535 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
0.1 | 0.3 | GO:0021634 | optic nerve formation(GO:0021634) regulation of metanephros size(GO:0035566) optic chiasma development(GO:0061360) regulation of optic nerve formation(GO:2000595) positive regulation of optic nerve formation(GO:2000597) |
0.1 | 1.0 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 0.4 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
0.1 | 0.9 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.3 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.4 | GO:1905169 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
0.1 | 0.3 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.1 | 1.1 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.1 | 0.2 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.1 | 0.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 2.2 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.3 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
0.1 | 1.2 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.1 | 0.7 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 1.5 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.1 | 1.0 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 1.4 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 2.7 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 0.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.3 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.1 | 0.2 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.2 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.1 | 0.3 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 0.3 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) |
0.1 | 0.5 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.3 | GO:0060482 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
0.1 | 0.1 | GO:0072095 | cranial ganglion development(GO:0061550) trigeminal ganglion development(GO:0061551) regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
0.1 | 0.1 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
0.1 | 0.3 | GO:0015786 | UDP-glucose transport(GO:0015786) |
0.1 | 0.2 | GO:0050755 | chemokine metabolic process(GO:0050755) |
0.1 | 0.5 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 0.2 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.1 | 0.2 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 3.8 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.1 | 0.3 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.1 | 1.4 | GO:0061525 | hindgut development(GO:0061525) |
0.1 | 1.2 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 0.4 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.1 | 0.2 | GO:0036245 | cellular response to menadione(GO:0036245) |
0.1 | 0.1 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.1 | 0.4 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.1 | 0.5 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 0.1 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.1 | 0.9 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.3 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.1 | 0.3 | GO:1902548 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.1 | 0.9 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 0.1 | GO:0048382 | mesendoderm development(GO:0048382) |
0.1 | 0.7 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 0.3 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.1 | 2.0 | GO:0048339 | paraxial mesoderm development(GO:0048339) |
0.1 | 0.8 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.3 | GO:1902811 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
0.1 | 1.6 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.1 | 0.6 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.1 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
0.1 | 1.2 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.1 | 0.6 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
0.1 | 0.7 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 1.1 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.1 | 1.0 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.1 | 0.4 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.4 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.1 | 0.1 | GO:0055095 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.1 | 1.3 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.1 | 0.2 | GO:1901994 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.1 | 1.6 | GO:1901160 | serotonin metabolic process(GO:0042428) primary amino compound metabolic process(GO:1901160) |
0.1 | 0.3 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.1 | 0.1 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.1 | 0.2 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.3 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.1 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.1 | 0.2 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 0.2 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.1 | 0.4 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.1 | 0.2 | GO:2000156 | regulation of retrograde vesicle-mediated transport, Golgi to ER(GO:2000156) |
0.1 | 0.5 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.1 | 3.8 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.2 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
0.1 | 0.8 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.1 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.1 | 0.5 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.1 | 0.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.2 | GO:0070843 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
0.1 | 4.1 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.1 | 0.3 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.1 | 0.3 | GO:0045991 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite activation of transcription(GO:0045991) |
0.1 | 0.2 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.1 | 0.2 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
0.1 | 0.2 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.1 | 0.4 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.1 | 0.3 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.1 | 0.1 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.1 | 0.2 | GO:0030472 | mitotic spindle organization in nucleus(GO:0030472) |
0.1 | 0.1 | GO:0060151 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
0.1 | 0.2 | GO:0031038 | myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
0.1 | 0.7 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.1 | 0.3 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.1 | 0.6 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 2.4 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.3 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.1 | 0.7 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.2 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.2 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.1 | 0.7 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.1 | 1.8 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.7 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.1 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 0.2 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.1 | 0.2 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.1 | 0.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 1.0 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 1.0 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 0.4 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 1.5 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 1.0 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.1 | 0.4 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.1 | 0.5 | GO:0015879 | carnitine transport(GO:0015879) |
0.1 | 0.2 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.1 | 0.4 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.1 | 0.2 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.6 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.4 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.1 | 1.1 | GO:0007398 | ectoderm development(GO:0007398) |
0.1 | 0.2 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
0.1 | 0.4 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.1 | 0.9 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.1 | 0.2 | GO:1902869 | regulation of amacrine cell differentiation(GO:1902869) |
0.1 | 0.1 | GO:1900212 | mesenchymal cell apoptotic process involved in metanephros development(GO:1900200) regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900211) negative regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900212) |
0.1 | 0.1 | GO:1904350 | regulation of protein catabolic process in the vacuole(GO:1904350) |
0.1 | 1.2 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.6 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.4 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) synaptic vesicle budding(GO:0070142) |
0.1 | 0.2 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
0.1 | 0.1 | GO:1901536 | negative regulation of DNA demethylation(GO:1901536) |
0.1 | 0.4 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.1 | 0.4 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.1 | 1.2 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.2 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.1 | 0.2 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.1 | 0.3 | GO:0014841 | skeletal muscle satellite cell proliferation(GO:0014841) regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.1 | 0.2 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.1 | GO:0034552 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.1 | 0.8 | GO:0021924 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.1 | 0.2 | GO:0051439 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051439) |
0.1 | 0.2 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.1 | 0.2 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.1 | 0.1 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
0.1 | 0.2 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.1 | 1.1 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.1 | 0.3 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.1 | 0.9 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.9 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.1 | 0.1 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.1 | 0.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.7 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.6 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 0.1 | GO:0006649 | phospholipid transfer to membrane(GO:0006649) |
0.1 | 0.1 | GO:0031104 | dendrite regeneration(GO:0031104) |
0.1 | 0.3 | GO:0051132 | NK T cell activation(GO:0051132) |
0.1 | 0.3 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.1 | GO:0002729 | positive regulation of natural killer cell cytokine production(GO:0002729) |
0.1 | 0.2 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.1 | GO:0090034 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
0.1 | 0.1 | GO:1990051 | activation of protein kinase C activity(GO:1990051) |
0.1 | 0.3 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.1 | 0.4 | GO:0097435 | fibril organization(GO:0097435) |
0.1 | 0.7 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.1 | 0.2 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.1 | 0.2 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.1 | 0.4 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 0.2 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.1 | 1.6 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.2 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.9 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.3 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.4 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 0.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.2 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.1 | 0.3 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.1 | 0.2 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.1 | 1.2 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.1 | 0.5 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.2 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.2 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
0.1 | 0.6 | GO:0045061 | thymic T cell selection(GO:0045061) |
0.1 | 0.6 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.1 | 0.1 | GO:0045976 | serotonergic neuron axon guidance(GO:0036515) negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
0.1 | 0.1 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.1 | 0.3 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.1 | 0.6 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 0.5 | GO:0061727 | methylglyoxal metabolic process(GO:0009438) methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.1 | 0.3 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.1 | 0.4 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.1 | 0.6 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 0.9 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.1 | 0.9 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 0.1 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
0.1 | 0.2 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
0.1 | 0.1 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.1 | 0.5 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.1 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
0.1 | 0.2 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.1 | 0.2 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.1 | 0.2 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.5 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.1 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.0 | 0.3 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 0.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.0 | 0.1 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.0 | 0.7 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.0 | 1.8 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.3 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.0 | 1.5 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.0 | 0.7 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.0 | 0.8 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 1.1 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 3.2 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.0 | 0.2 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.4 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 0.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.1 | GO:0048289 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.0 | 0.1 | GO:0035246 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine N-methylation(GO:0035246) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.0 | 0.1 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.0 | 0.2 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.0 | 0.0 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.0 | 0.1 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
0.0 | 0.3 | GO:0060174 | limb bud formation(GO:0060174) |
0.0 | 0.5 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.0 | 1.4 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.0 | 0.1 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
0.0 | 0.4 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.0 | 2.0 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 0.0 | GO:0099550 | trans-synaptic signalling, modulating synaptic transmission(GO:0099550) |
0.0 | 1.0 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.6 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.6 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.0 | 0.6 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 0.5 | GO:0033561 | regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
0.0 | 0.5 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.5 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.0 | 1.7 | GO:0042775 | mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
0.0 | 0.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.4 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.7 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.0 | 0.4 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.0 | 0.8 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.6 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.0 | 0.7 | GO:0006241 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.0 | 0.2 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.0 | 0.1 | GO:0061026 | lung lobe formation(GO:0060464) diaphragm morphogenesis(GO:0060540) cardiac muscle tissue regeneration(GO:0061026) |
0.0 | 0.4 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.0 | 2.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.2 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
0.0 | 0.2 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) negative regulation of Fas signaling pathway(GO:1902045) |
0.0 | 0.1 | GO:0038156 | interleukin-3-mediated signaling pathway(GO:0038156) |
0.0 | 0.3 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.0 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.8 | GO:0098868 | bone growth(GO:0098868) |
0.0 | 0.3 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.0 | 0.3 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.0 | 0.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.1 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.0 | 0.9 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.0 | 0.7 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.0 | 1.1 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.0 | 0.4 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.0 | 1.0 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.2 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.0 | 0.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.2 | GO:0003383 | apical constriction(GO:0003383) |
0.0 | 0.2 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.0 | 0.3 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.0 | 0.3 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
0.0 | 0.1 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
0.0 | 0.3 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.6 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 0.4 | GO:0031103 | axon regeneration(GO:0031103) |
0.0 | 0.2 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.0 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 1.9 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.0 | 0.2 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.0 | 0.3 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.3 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.0 | 0.4 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.0 | 0.1 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.0 | 1.0 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.0 | 0.3 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.0 | 0.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.2 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.0 | 0.1 | GO:0042737 | drug catabolic process(GO:0042737) |
0.0 | 0.0 | GO:0072197 | ureter morphogenesis(GO:0072197) |
0.0 | 0.3 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.0 | 0.1 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.0 | 0.3 | GO:0035567 | non-canonical Wnt signaling pathway(GO:0035567) |
0.0 | 0.1 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
0.0 | 0.9 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.0 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.0 | 0.2 | GO:0035729 | cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.0 | 0.1 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.0 | 0.1 | GO:0038016 | insulin receptor internalization(GO:0038016) |
0.0 | 0.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.1 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.0 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.3 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.0 | 0.2 | GO:0050757 | thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
0.0 | 0.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.3 | GO:2000737 | negative regulation of stem cell differentiation(GO:2000737) |
0.0 | 0.4 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.1 | GO:0034959 | neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.0 | 0.1 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.0 | 0.2 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.3 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.0 | 0.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.0 | 0.2 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.0 | 1.0 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.2 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 0.1 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.0 | 0.1 | GO:0046386 | deoxyribose phosphate catabolic process(GO:0046386) |
0.0 | 0.1 | GO:0015817 | histidine transport(GO:0015817) |
0.0 | 0.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.4 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.0 | 0.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.0 | 0.0 | GO:0006404 | RNA import into nucleus(GO:0006404) |
0.0 | 0.1 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.0 | 0.1 | GO:0060596 | mammary placode formation(GO:0060596) |
0.0 | 0.4 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.0 | 0.3 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.1 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.0 | 0.2 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.0 | 0.4 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.0 | 0.2 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.3 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 0.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.0 | 0.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.1 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.0 | 0.3 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.0 | 0.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.0 | 0.1 | GO:0071351 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
0.0 | 0.1 | GO:0016598 | protein arginylation(GO:0016598) |
0.0 | 0.3 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.0 | 0.2 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.0 | 0.6 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.1 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) |
0.0 | 0.1 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.4 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.0 | 3.6 | GO:0030198 | extracellular matrix organization(GO:0030198) |
0.0 | 0.1 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.0 | 0.1 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.0 | 0.1 | GO:0002676 | regulation of chronic inflammatory response(GO:0002676) |
0.0 | 0.4 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.0 | 0.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.0 | 0.1 | GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
0.0 | 0.1 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
0.0 | 0.2 | GO:0034405 | response to fluid shear stress(GO:0034405) |
0.0 | 0.0 | GO:1900275 | negative regulation of phospholipase C activity(GO:1900275) |
0.0 | 0.4 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.0 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.0 | 0.2 | GO:0006183 | GMP biosynthetic process(GO:0006177) GTP biosynthetic process(GO:0006183) |
0.0 | 0.0 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) regulation of natural killer cell differentiation involved in immune response(GO:0032826) |
0.0 | 0.1 | GO:0034143 | regulation of toll-like receptor 4 signaling pathway(GO:0034143) |
0.0 | 0.1 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) regulation of macrophage inflammatory protein 1 alpha production(GO:0071640) |
0.0 | 0.2 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
0.0 | 0.4 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 0.2 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.1 | GO:0035627 | ceramide transport(GO:0035627) |
0.0 | 0.6 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.0 | 0.3 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.0 | 0.1 | GO:1903028 | regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
0.0 | 0.2 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.0 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.2 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.0 | 0.2 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.0 | 0.2 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.0 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.0 | 0.2 | GO:0090177 | establishment of planar polarity of embryonic epithelium(GO:0042249) establishment of planar polarity involved in neural tube closure(GO:0090177) |
0.0 | 0.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.0 | 0.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.0 | 0.4 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 0.2 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.0 | 0.1 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.0 | 0.4 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.0 | 0.5 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.0 | 0.1 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
0.0 | 0.1 | GO:0010705 | meiotic DNA double-strand break processing involved in reciprocal meiotic recombination(GO:0010705) |
0.0 | 0.5 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 0.1 | GO:0007314 | oocyte construction(GO:0007308) oocyte axis specification(GO:0007309) oocyte anterior/posterior axis specification(GO:0007314) pole plasm assembly(GO:0007315) maternal determination of anterior/posterior axis, embryo(GO:0008358) P granule organization(GO:0030719) |
0.0 | 0.1 | GO:0018364 | box C/D snoRNA 3'-end processing(GO:0000494) peptidyl-glutamine methylation(GO:0018364) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
0.0 | 0.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.0 | 0.4 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.0 | 0.1 | GO:0061056 | sclerotome development(GO:0061056) |
0.0 | 0.2 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.0 | 0.4 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.0 | 0.3 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.0 | 0.5 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.0 | 0.5 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.0 | 2.0 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.0 | 0.1 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.0 | 0.1 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.0 | 0.0 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.0 | 0.0 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.0 | 0.1 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.0 | 0.5 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.2 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.0 | GO:0070194 | synaptonemal complex disassembly(GO:0070194) |
0.0 | 0.1 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.0 | 0.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.6 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
0.0 | 0.1 | GO:0032298 | positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
0.0 | 0.1 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.0 | 0.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.1 | GO:0048678 | response to axon injury(GO:0048678) |
0.0 | 0.1 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.0 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.0 | 0.4 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.1 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.0 | 0.0 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.0 | 0.4 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.4 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.4 | GO:0021983 | pituitary gland development(GO:0021983) |
0.0 | 0.3 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.2 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.0 | 0.0 | GO:0033684 | regulation of luteinizing hormone secretion(GO:0033684) |
0.0 | 0.1 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.0 | 0.1 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.0 | 0.2 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.2 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.4 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.0 | 0.3 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 0.0 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.0 | 0.4 | GO:0032402 | melanosome transport(GO:0032402) |
0.0 | 0.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.0 | 0.2 | GO:0010470 | regulation of gastrulation(GO:0010470) |
0.0 | 0.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.4 | GO:0006029 | proteoglycan metabolic process(GO:0006029) |
0.0 | 0.3 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.1 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.0 | 0.4 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.0 | 0.3 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.0 | 0.1 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.0 | 0.2 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.2 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.0 | 0.0 | GO:0021594 | rhombomere formation(GO:0021594) rhombomere 3 formation(GO:0021660) rhombomere 5 morphogenesis(GO:0021664) rhombomere 5 formation(GO:0021666) |
0.0 | 0.2 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.0 | 0.1 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.0 | 0.2 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.0 | 0.4 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.0 | 0.0 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.0 | 0.1 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.0 | 0.1 | GO:0051012 | microtubule sliding(GO:0051012) |
0.0 | 0.0 | GO:0098961 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
0.0 | 0.3 | GO:1900077 | negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.0 | 0.0 | GO:0030974 | thiamine pyrophosphate transport(GO:0030974) |
0.0 | 0.1 | GO:0098706 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.0 | 0.1 | GO:0042762 | regulation of sulfur metabolic process(GO:0042762) positive regulation of sulfur metabolic process(GO:0051176) |
0.0 | 0.0 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.0 | 0.0 | GO:0006583 | melanin biosynthetic process from tyrosine(GO:0006583) |
0.0 | 0.3 | GO:0001709 | cell fate determination(GO:0001709) |
0.0 | 0.1 | GO:0061083 | regulation of protein refolding(GO:0061083) |
0.0 | 0.4 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.0 | 0.3 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.0 | 0.1 | GO:0019471 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) |
0.0 | 0.1 | GO:0018377 | protein myristoylation(GO:0018377) |
0.0 | 0.0 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.0 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.0 | 0.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.1 | GO:0006848 | pyruvate transport(GO:0006848) |
0.0 | 0.0 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.0 | 0.1 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.0 | 0.1 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.0 | 0.1 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.0 | 0.1 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.0 | 0.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.0 | 0.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 0.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.0 | 0.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.1 | GO:1900004 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.0 | 0.0 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.1 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
0.0 | 0.2 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.0 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.0 | GO:1900120 | regulation of receptor binding(GO:1900120) |
0.0 | 0.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.2 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.0 | GO:0021546 | rhombomere development(GO:0021546) |
0.0 | 0.0 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.0 | 0.1 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.0 | 0.0 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.0 | 0.1 | GO:0071800 | podosome assembly(GO:0071800) |
0.0 | 0.2 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.0 | 0.1 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) |
0.0 | 0.1 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.0 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.0 | 0.3 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.0 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.0 | 0.1 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.0 | 0.0 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.0 | 0.1 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.0 | 0.0 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.0 | 0.2 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.0 | 0.0 | GO:0098722 | asymmetric stem cell division(GO:0098722) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 1.8 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.9 | 4.3 | GO:0071953 | elastic fiber(GO:0071953) |
0.8 | 2.4 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.6 | 6.3 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.6 | 2.4 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.6 | 22.4 | GO:0042588 | zymogen granule(GO:0042588) |
0.6 | 12.7 | GO:0042627 | chylomicron(GO:0042627) |
0.5 | 1.4 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.5 | 1.4 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
0.5 | 2.8 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.4 | 1.3 | GO:0097361 | CIA complex(GO:0097361) |
0.4 | 0.8 | GO:0098842 | postsynaptic early endosome(GO:0098842) |
0.4 | 2.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.3 | 2.1 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.3 | 11.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 1.0 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.3 | 0.9 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.3 | 0.8 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.3 | 1.3 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.3 | 6.6 | GO:0032426 | stereocilium tip(GO:0032426) |
0.3 | 1.0 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.2 | 6.2 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 0.7 | GO:0005584 | collagen type I trimer(GO:0005584) |
0.2 | 1.5 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.2 | 5.2 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.2 | 0.9 | GO:0045273 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.2 | 2.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 3.7 | GO:0043203 | axon hillock(GO:0043203) |
0.2 | 0.6 | GO:1990031 | pinceau fiber(GO:1990031) |
0.2 | 1.2 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
0.2 | 2.2 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.2 | 0.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 0.8 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 1.7 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 1.4 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 1.2 | GO:0097444 | spine apparatus(GO:0097444) |
0.2 | 0.7 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
0.2 | 0.7 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.2 | 2.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 2.6 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 1.5 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.2 | 1.5 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.2 | 1.8 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.2 | 2.0 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 0.5 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.2 | 0.6 | GO:0035976 | AP1 complex(GO:0035976) |
0.2 | 0.8 | GO:0005914 | spot adherens junction(GO:0005914) |
0.2 | 2.1 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 3.4 | GO:0097449 | astrocyte projection(GO:0097449) |
0.1 | 0.4 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.1 | 0.1 | GO:0034683 | integrin alphav-beta3 complex(GO:0034683) |
0.1 | 0.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.7 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
0.1 | 1.9 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 3.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.6 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.4 | GO:0044317 | rod spherule(GO:0044317) |
0.1 | 1.0 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.8 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.1 | 2.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 2.1 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.9 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 1.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 0.9 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
0.1 | 0.8 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 2.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.4 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.1 | 0.3 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.1 | 1.6 | GO:0016011 | dystroglycan complex(GO:0016011) |
0.1 | 2.0 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 1.4 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 0.9 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 1.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 0.5 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.9 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 0.6 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.1 | 3.3 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 0.5 | GO:0097447 | dendritic tree(GO:0097447) |
0.1 | 1.6 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 0.3 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.1 | 0.5 | GO:0005745 | m-AAA complex(GO:0005745) |
0.1 | 0.3 | GO:0098830 | presynaptic endosome(GO:0098830) |
0.1 | 0.5 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 3.4 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.8 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.3 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
0.1 | 28.8 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.4 | GO:0044393 | microspike(GO:0044393) |
0.1 | 0.6 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.3 | GO:0002945 | cyclin K-CDK12 complex(GO:0002944) cyclin K-CDK13 complex(GO:0002945) |
0.1 | 1.1 | GO:0097386 | glial cell projection(GO:0097386) |
0.1 | 0.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.5 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 1.1 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 1.4 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 0.4 | GO:1990429 | Pex17p-Pex14p docking complex(GO:1990415) peroxisomal importomer complex(GO:1990429) |
0.1 | 1.5 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 1.0 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.3 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.1 | 0.3 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.4 | GO:1990795 | lateral part of cell(GO:0097574) basolateral part of cell(GO:1990794) rod bipolar cell terminal bouton(GO:1990795) |
0.1 | 1.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.3 | GO:0097144 | BAX complex(GO:0097144) |
0.1 | 2.3 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 0.2 | GO:0044753 | amphisome(GO:0044753) |
0.1 | 0.4 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
0.1 | 3.2 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 2.7 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 1.6 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.2 | GO:0036501 | UFD1-NPL4 complex(GO:0036501) |
0.1 | 147.3 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 0.4 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.4 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 1.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.2 | GO:0034456 | CURI complex(GO:0032545) UTP-C complex(GO:0034456) |
0.1 | 0.5 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 1.0 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 1.6 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.3 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
0.1 | 0.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.1 | 0.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 3.5 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 12.4 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.1 | 0.2 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.1 | 0.8 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.3 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.1 | 1.0 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.3 | GO:0045160 | myosin I complex(GO:0045160) |
0.1 | 0.2 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.1 | 0.3 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.1 | 0.5 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.7 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 0.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.1 | 1.6 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.5 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.6 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
0.1 | 0.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 0.2 | GO:1990696 | USH2 complex(GO:1990696) |
0.1 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.2 | GO:0043219 | lateral loop(GO:0043219) |
0.1 | 0.3 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 3.2 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.3 | GO:0017177 | glucosidase II complex(GO:0017177) |
0.1 | 0.9 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 0.3 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.2 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.1 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.0 | 0.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.2 | GO:0035363 | histone locus body(GO:0035363) |
0.0 | 3.6 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.7 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.9 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.0 | 3.0 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 0.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.2 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.3 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.0 | 1.1 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.5 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.0 | 0.7 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 2.4 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 2.1 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.8 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 0.4 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.0 | 2.1 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.8 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 1.4 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.8 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 2.6 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 1.3 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.6 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 0.1 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.0 | 0.5 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.0 | 0.9 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.0 | 0.0 | GO:0005757 | mitochondrial permeability transition pore complex(GO:0005757) |
0.0 | 0.2 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.0 | 1.2 | GO:0031228 | integral component of Golgi membrane(GO:0030173) intrinsic component of Golgi membrane(GO:0031228) |
0.0 | 0.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.6 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.0 | 0.2 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.0 | 0.0 | GO:1902710 | GABA receptor complex(GO:1902710) |
0.0 | 0.6 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.2 | GO:0070069 | cytochrome complex(GO:0070069) |
0.0 | 0.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.1 | GO:0043256 | laminin complex(GO:0043256) |
0.0 | 0.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.6 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 0.1 | GO:0098855 | HCN channel complex(GO:0098855) |
0.0 | 0.7 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.3 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 0.2 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.0 | 0.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.0 | 0.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.0 | 0.3 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.0 | 0.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.0 | 1.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 10.3 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 1.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.5 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.1 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
0.0 | 0.3 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.1 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.3 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 0.6 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.5 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.3 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.9 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.7 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.1 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.0 | GO:0034271 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.0 | 0.2 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.3 | GO:0061702 | inflammasome complex(GO:0061702) |
0.0 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 2.0 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.1 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
0.0 | 0.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.3 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 96.1 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
0.0 | 0.5 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.2 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.3 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 0.2 | GO:0032797 | SMN complex(GO:0032797) |
0.0 | 0.0 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.0 | 0.1 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 0.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 1.1 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.0 | 0.1 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.1 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.0 | 0.2 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.1 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 0.1 | GO:0031251 | PAN complex(GO:0031251) |
0.0 | 0.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.0 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.0 | 0.1 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.0 | 1.2 | GO:0016363 | nuclear matrix(GO:0016363) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.1 | 12.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
2.6 | 2.6 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
1.7 | 6.8 | GO:0047016 | cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity(GO:0047016) |
1.7 | 6.7 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
1.2 | 4.9 | GO:0016708 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
1.2 | 7.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
1.1 | 8.7 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
1.0 | 3.1 | GO:0004371 | glycerone kinase activity(GO:0004371) FAD-AMP lyase (cyclizing) activity(GO:0034012) triokinase activity(GO:0050354) |
1.0 | 2.9 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.9 | 2.8 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
0.9 | 2.7 | GO:0015152 | glucose-6-phosphate transmembrane transporter activity(GO:0015152) |
0.9 | 3.5 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.8 | 5.7 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.7 | 2.2 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
0.7 | 4.3 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.7 | 8.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.6 | 1.9 | GO:0008775 | acetate CoA-transferase activity(GO:0008775) |
0.6 | 2.5 | GO:0004103 | choline kinase activity(GO:0004103) |
0.6 | 1.9 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) uniporter activity(GO:0015292) |
0.6 | 1.8 | GO:0008127 | 4-hydroxyphenylpyruvate dioxygenase activity(GO:0003868) quercetin 2,3-dioxygenase activity(GO:0008127) |
0.6 | 5.4 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.6 | 2.4 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
0.5 | 3.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.5 | 1.6 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.5 | 4.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.5 | 1.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.5 | 1.5 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.5 | 1.4 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.5 | 1.9 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.5 | 1.4 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.5 | 3.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.5 | 1.8 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.5 | 1.4 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.5 | 1.4 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.5 | 1.4 | GO:0070279 | vitamin B6 binding(GO:0070279) |
0.4 | 9.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.4 | 2.6 | GO:0008142 | oxysterol binding(GO:0008142) |
0.4 | 4.7 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.4 | 1.7 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.4 | 1.3 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.4 | 6.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.4 | 2.0 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.4 | 1.6 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.4 | 87.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.4 | 4.7 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.4 | 9.1 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.4 | 4.5 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.4 | 1.9 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.4 | 4.5 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.4 | 1.1 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
0.4 | 5.9 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.4 | 13.5 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.4 | 4.0 | GO:0035473 | lipase binding(GO:0035473) |
0.4 | 11.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.3 | 2.1 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.3 | 0.3 | GO:0045118 | azole transporter activity(GO:0045118) |
0.3 | 8.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.3 | 1.0 | GO:0031755 | endothelial differentiation G-protein coupled receptor binding(GO:0031753) Edg-2 lysophosphatidic acid receptor binding(GO:0031755) |
0.3 | 1.0 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
0.3 | 1.9 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.3 | 1.0 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
0.3 | 1.3 | GO:0019862 | IgA binding(GO:0019862) |
0.3 | 4.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.3 | 2.2 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.3 | 1.3 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.3 | 0.6 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.3 | 0.9 | GO:0003999 | adenine binding(GO:0002055) adenine phosphoribosyltransferase activity(GO:0003999) |
0.3 | 1.8 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.3 | 1.2 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.3 | 0.6 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
0.3 | 1.2 | GO:0005118 | sevenless binding(GO:0005118) |
0.3 | 0.6 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.3 | 0.9 | GO:0002058 | uracil binding(GO:0002058) pyrimidine nucleobase binding(GO:0002061) |
0.3 | 1.4 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.3 | 3.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.3 | 0.8 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) |
0.3 | 0.8 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.3 | 0.8 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.3 | 1.4 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.3 | 3.5 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.3 | 0.8 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.3 | 1.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.3 | 1.1 | GO:0047874 | dolichyldiphosphatase activity(GO:0047874) |
0.3 | 1.0 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.3 | 1.0 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.3 | 6.2 | GO:0001618 | virus receptor activity(GO:0001618) |
0.3 | 4.6 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.3 | 1.0 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.3 | 1.0 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.2 | 2.0 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.2 | 0.7 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.2 | 1.2 | GO:0009384 | N-acylmannosamine kinase activity(GO:0009384) |
0.2 | 1.0 | GO:0051435 | BH4 domain binding(GO:0051435) |
0.2 | 0.7 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.2 | 1.7 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.2 | 0.7 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.2 | 1.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 1.6 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.2 | 0.7 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 0.9 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.2 | 0.7 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.2 | 1.2 | GO:2001069 | glycogen binding(GO:2001069) |
0.2 | 1.8 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 0.7 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.2 | 1.8 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.2 | 0.9 | GO:0045159 | myosin II binding(GO:0045159) |
0.2 | 0.7 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.2 | 1.1 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.2 | 0.9 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.2 | 0.9 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 9.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 3.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 5.1 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.2 | 1.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 1.9 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 2.5 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.2 | 1.0 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.2 | 1.2 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 0.6 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
0.2 | 0.6 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.2 | 0.2 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.2 | 0.8 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.2 | 1.4 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 0.6 | GO:0035478 | chylomicron binding(GO:0035478) |
0.2 | 1.5 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.2 | 0.6 | GO:0016034 | maleylacetoacetate isomerase activity(GO:0016034) |
0.2 | 1.1 | GO:0032810 | sterol response element binding(GO:0032810) |
0.2 | 1.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 0.7 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.2 | 1.3 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.2 | 0.7 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.2 | 0.5 | GO:0008520 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.2 | 1.3 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.2 | 0.7 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.2 | 6.0 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.2 | 0.5 | GO:0070025 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitric oxide binding(GO:0070026) |
0.2 | 0.5 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.2 | 0.7 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.2 | 1.0 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.2 | 1.0 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.2 | 6.9 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 5.2 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.2 | 0.9 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.2 | 0.5 | GO:0016872 | inositol-3-phosphate synthase activity(GO:0004512) intramolecular lyase activity(GO:0016872) |
0.2 | 1.0 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.2 | 0.5 | GO:0004326 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) |
0.2 | 0.3 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.2 | 0.7 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.2 | 0.2 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.2 | 1.8 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.2 | 1.0 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.2 | 1.0 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.2 | 0.6 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
0.2 | 0.5 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.2 | 1.0 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.2 | 0.6 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.2 | 0.8 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.2 | 1.0 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.2 | 1.1 | GO:0048185 | activin binding(GO:0048185) |
0.2 | 2.7 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 1.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 0.5 | GO:0052895 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
0.2 | 1.4 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.2 | 1.7 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.2 | 1.5 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
0.2 | 0.3 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
0.2 | 1.5 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 1.2 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.2 | 1.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.2 | 0.8 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 0.6 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 1.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 1.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.6 | GO:0030294 | receptor signaling protein tyrosine kinase inhibitor activity(GO:0030294) |
0.1 | 0.7 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 0.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.1 | 0.6 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.1 | 0.4 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.1 | 1.6 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.4 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.1 | 2.0 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.4 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 0.6 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 1.0 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 17.2 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.8 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.1 | 1.2 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 1.7 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 1.1 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.1 | 1.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.4 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
0.1 | 0.5 | GO:0004736 | pyruvate carboxylase activity(GO:0004736) |
0.1 | 0.5 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 1.5 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.3 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 0.4 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.7 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.1 | 0.7 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
0.1 | 1.9 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.9 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.1 | 1.1 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 0.7 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 2.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.4 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.1 | 0.9 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.1 | 0.5 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.9 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 0.5 | GO:0004092 | carnitine O-acetyltransferase activity(GO:0004092) |
0.1 | 0.8 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 1.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 0.4 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.1 | 1.0 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 0.8 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 0.8 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.1 | 0.8 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.1 | 0.4 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.1 | 0.5 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
0.1 | 0.4 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.1 | 17.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.5 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.1 | 0.4 | GO:0086059 | voltage-gated calcium channel activity involved SA node cell action potential(GO:0086059) |
0.1 | 0.5 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.1 | 0.5 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.1 | 3.1 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 0.3 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 0.9 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.6 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.2 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.1 | 1.8 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 2.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 0.1 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.1 | 0.8 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 1.1 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 2.7 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 0.2 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) glycerol transmembrane transporter activity(GO:0015168) |
0.1 | 1.2 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.3 | GO:0070540 | stearic acid binding(GO:0070540) |
0.1 | 0.8 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 2.0 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.3 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.1 | 0.3 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.7 | GO:0030172 | troponin C binding(GO:0030172) |
0.1 | 0.2 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.7 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.5 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 2.0 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 1.0 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 4.1 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 2.2 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 1.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.3 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.1 | 0.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.7 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.1 | 5.4 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.6 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.3 | GO:0098918 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
0.1 | 1.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 1.5 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.3 | GO:0019981 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
0.1 | 0.2 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 0.5 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.8 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 1.0 | GO:0050544 | icosanoid binding(GO:0050542) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.1 | 0.3 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.1 | 1.4 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 0.3 | GO:0004454 | ketohexokinase activity(GO:0004454) |
0.1 | 1.0 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.3 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.1 | 1.4 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.8 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 1.4 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 0.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.1 | 11.4 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 0.6 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 0.9 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 0.3 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
0.1 | 0.3 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.3 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.1 | 1.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 1.7 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.3 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.4 | GO:0019779 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
0.1 | 0.6 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 1.7 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.2 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.1 | 0.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 0.5 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.3 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.1 | 3.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.3 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.9 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 0.5 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.1 | 1.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.7 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.7 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.8 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.5 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.8 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) ATP transmembrane transporter activity(GO:0005347) purine nucleotide transmembrane transporter activity(GO:0015216) ADP transmembrane transporter activity(GO:0015217) |
0.1 | 1.8 | GO:0016594 | glycine binding(GO:0016594) |
0.1 | 0.3 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.1 | 0.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.6 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 1.7 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 5.1 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 0.3 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.1 | 5.6 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.3 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 0.4 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 2.1 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.2 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.1 | 0.3 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
0.1 | 0.2 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 0.2 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.1 | 0.6 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 0.2 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.1 | 0.3 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 1.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.3 | GO:0045183 | translation factor activity, non-nucleic acid binding(GO:0045183) |
0.1 | 0.7 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 0.5 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 1.6 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.1 | 0.3 | GO:0086038 | calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086038) |
0.1 | 2.3 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.4 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.1 | 0.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 4.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.2 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.1 | 0.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 1.9 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 0.6 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 1.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.2 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.3 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 3.3 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.3 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 0.5 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.3 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 0.2 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
0.1 | 0.3 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
0.1 | 0.3 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.3 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
0.1 | 0.3 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.1 | 0.2 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.1 | 0.5 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.1 | 0.5 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.1 | 0.9 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.3 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.2 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.1 | 0.3 | GO:0001032 | RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
0.1 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.2 | GO:0010428 | methyl-CpNpG binding(GO:0010428) |
0.1 | 1.8 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 0.2 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.1 | 0.4 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.9 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 0.2 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
0.1 | 0.3 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.1 | 0.3 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.1 | 0.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.2 | GO:0050436 | microfibril binding(GO:0050436) |
0.1 | 0.2 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.1 | 0.2 | GO:0004615 | phosphomannomutase activity(GO:0004615) |
0.1 | 1.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 0.5 | GO:0005124 | scavenger receptor binding(GO:0005124) |
0.1 | 0.1 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 0.4 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.2 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 1.0 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.2 | GO:0072541 | peroxynitrite reductase activity(GO:0072541) |
0.1 | 0.6 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.1 | 0.1 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
0.1 | 0.9 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.1 | 3.5 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.2 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.7 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 0.1 | GO:0090555 | phosphatidylethanolamine-translocating ATPase activity(GO:0090555) |
0.1 | 1.0 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.3 | GO:0070404 | NADH binding(GO:0070404) |
0.1 | 0.3 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.1 | 0.3 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 1.4 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 0.8 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.5 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.2 | GO:0035516 | oxidative DNA demethylase activity(GO:0035516) RNA N6-methyladenosine dioxygenase activity(GO:1990931) |
0.1 | 0.9 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.1 | 0.4 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 1.8 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.2 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.1 | 0.2 | GO:1990955 | G-rich single-stranded DNA binding(GO:1990955) |
0.1 | 0.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.3 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 0.4 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.2 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 0.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.2 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.1 | 0.2 | GO:0030629 | U6 snRNA 3'-end binding(GO:0030629) |
0.1 | 0.3 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.1 | 0.3 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.1 | 0.1 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.1 | 0.5 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 1.7 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 1.3 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 1.9 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.2 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.0 | 1.5 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 0.7 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.4 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.0 | 0.3 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.4 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.0 | 0.8 | GO:0031005 | filamin binding(GO:0031005) |
0.0 | 0.2 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.0 | 1.6 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.1 | GO:0042806 | fucose binding(GO:0042806) |
0.0 | 1.4 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.5 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.7 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.0 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.0 | 0.2 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.0 | 0.2 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.4 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.0 | 0.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.1 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.0 | 0.0 | GO:0031208 | POZ domain binding(GO:0031208) |
0.0 | 0.2 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 0.1 | GO:0019978 | interleukin-3 receptor activity(GO:0004912) interleukin-3 binding(GO:0019978) |
0.0 | 0.2 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.0 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.2 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.0 | 0.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.0 | 1.0 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.0 | 1.0 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.1 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
0.0 | 0.2 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.0 | 0.0 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.0 | 0.2 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 0.4 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 5.0 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.2 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 1.9 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.1 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.0 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.1 | GO:0070039 | rRNA (guanosine-2'-O-)-methyltransferase activity(GO:0070039) |
0.0 | 0.3 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.0 | 1.1 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.0 | 0.2 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.1 | GO:0052692 | raffinose alpha-galactosidase activity(GO:0052692) |
0.0 | 0.6 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.8 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.4 | GO:0043426 | MRF binding(GO:0043426) |
0.0 | 0.1 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.4 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.2 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 0.2 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.0 | 0.3 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.7 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.1 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.0 | 0.1 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.0 | 0.1 | GO:0044020 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.0 | 0.2 | GO:0005536 | glucose binding(GO:0005536) |
0.0 | 0.1 | GO:0043734 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.0 | 0.6 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.0 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 0.6 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.3 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.4 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.0 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.0 | 0.3 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.0 | 0.2 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 1.3 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.0 | 0.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.4 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.1 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.5 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 1.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.2 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.0 | 0.5 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.1 | GO:0047291 | lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
0.0 | 0.2 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.0 | 0.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.2 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.0 | 0.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 4.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.4 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 0.1 | GO:0042008 | interleukin-18 receptor activity(GO:0042008) |
0.0 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.2 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.3 | GO:0032813 | death receptor binding(GO:0005123) tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.0 | 0.1 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.0 | 0.2 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.0 | 0.5 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.0 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.3 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.0 | 1.9 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.1 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.0 | 1.3 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.0 | 0.4 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.1 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.0 | 0.1 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.0 | 0.1 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 0.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.1 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.0 | 0.1 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.0 | 1.0 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.8 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.5 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.1 | GO:0051381 | histamine binding(GO:0051381) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.1 | GO:0036009 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.1 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 1.9 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.2 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.1 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.2 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.0 | 0.1 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.0 | 1.0 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 4.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 0.5 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.2 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 0.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.0 | 12.9 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.0 | 0.1 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.0 | 0.2 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.5 | GO:1905030 | voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.6 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.5 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.7 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.1 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.1 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.6 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.2 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.3 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.0 | 0.2 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.1 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.0 | 0.3 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.1 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 0.0 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 0.7 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.3 | GO:0032183 | SUMO binding(GO:0032183) |
0.0 | 0.1 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.0 | 0.2 | GO:0031701 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.1 | GO:0051870 | methotrexate binding(GO:0051870) |
0.0 | 0.1 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.0 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.0 | 0.0 | GO:0042936 | dipeptide transporter activity(GO:0042936) |
0.0 | 0.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 0.1 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.0 | 0.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.0 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.0 | 0.1 | GO:0001601 | peptide YY receptor activity(GO:0001601) pancreatic polypeptide receptor activity(GO:0001602) |
0.0 | 0.1 | GO:0015250 | water channel activity(GO:0015250) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 7.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.3 | 4.7 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 2.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 8.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 58.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 1.5 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.2 | 0.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 1.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 7.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 11.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 4.9 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 0.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 26.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.6 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 0.4 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 0.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 1.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 1.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 4.4 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 0.7 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 7.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 0.6 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 3.7 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 2.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.7 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 7.0 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 0.8 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 2.0 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 2.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 3.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 2.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 2.2 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 0.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 1.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 1.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.7 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 1.7 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 1.1 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 1.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 1.0 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.5 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 1.8 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 1.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 8.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 3.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 13.7 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 0.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 2.3 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.3 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.9 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 1.0 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 2.1 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 1.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.6 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.7 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.3 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 0.7 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
0.0 | 0.7 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.4 | PID BMP PATHWAY | BMP receptor signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 5.9 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.6 | 8.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.6 | 22.7 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.5 | 14.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.4 | 10.6 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.4 | 13.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.4 | 7.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.3 | 10.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.3 | 6.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.3 | 4.3 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.2 | 6.7 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.2 | 10.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 6.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 1.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 1.3 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.2 | 4.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 11.0 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 2.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 4.1 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.2 | 3.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 3.9 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.2 | 2.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 2.8 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 2.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.2 | 2.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 3.5 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 0.8 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 4.0 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 6.0 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 3.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 2.7 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 4.3 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 1.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 13.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 2.6 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 6.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 0.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 3.0 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 0.5 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.1 | 1.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 1.4 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 5.0 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 1.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 0.2 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 1.1 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.1 | 1.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 3.4 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.1 | 1.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 1.9 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 1.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 1.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 1.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 1.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 1.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 1.7 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 3.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 2.0 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 1.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 0.8 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 3.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 1.8 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 0.6 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 1.0 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 1.9 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 1.6 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 1.1 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 0.1 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.1 | 0.6 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 4.1 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.1 | 0.9 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 1.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.7 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 0.9 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 1.0 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 0.9 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 0.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 3.1 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 0.3 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 9.5 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 0.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 0.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 1.6 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 1.7 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.0 | 0.2 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.0 | 2.0 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 3.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.6 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.6 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.0 | 1.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 4.0 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.0 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.0 | 0.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.2 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.0 | 0.4 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.3 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 4.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 1.2 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.5 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 2.5 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 1.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.7 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.5 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.6 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.5 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.0 | 0.9 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.0 | 0.2 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.2 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 1.1 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.8 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 2.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.5 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.3 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.0 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.2 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.1 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.0 | 0.4 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |